Moa Life Plus

Moa Life Plus Current Assets

The Current Assets of Moa Life Plus (142760.KQ) as of Oct 30, 2026 is 2.40 B KRW. In the previous year, Current Assets was 45.88 B KRW — a change of -94.77% (lower).

Current Assets

2.40 BKRW

YoY

-94.77%

Last updated:

Current Assets of Moa Life Plus is 2025 2.40 B KRW. Current Assets of Moa Life Plus was 2024 45.88 B KRW. It decreases by -94.77% lower compared to the previous year.

The Moa Life Plus Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
69.11 B KRW
Jan 1, 2019
66.60 B KRW
Jan 1, 2020
73.40 B KRW
Jan 1, 2021
97.18 B KRW
Jan 1, 2022
71.54 B KRW
Jan 1, 2023
29.74 B KRW
Jan 1, 2024
45.88 B KRW
Jan 1, 2025
2.40 B KRW
The Moa Life Plus Current Assets history
YEARCurrent AssetsYoY
2.40 BKRW-94.77%
45.88 BKRW+54.26%
29.74 BKRW-58.42%
71.54 BKRW-26.39%
97.18 BKRW+32.40%
73.40 BKRW+10.21%
66.60 BKRW-3.62%
69.11 BKRW+123.76%
30.89 BKRW+75.89%
17.56 BKRW+126.84%
7.74 BKRW-1.04%
7.82 BKRW+4.80%
7.46 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

Current Assets of Moa Life Plus is 2.40 B KRW in 2025.

Current Assets of Moa Life Plus changed from 45.88 B KRW to 2.40 B KRW, representing a -94.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Moa Life Plus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Moa Life Plus

All Key Metrics — Moa Life Plus